Last updated: March 4, 2024
Sponsor: Kaneka Medical America LLC
Overall Status: Active - Recruiting
Phase
N/A
Condition
Aneurysm
Treatment
i-ED COIL
Clinical Study ID
NCT05563051
KMA-IVRNV-001
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Target aneurysm of 4mm - 14mm in size
- Ruptured or unruptured
- Suitable for embolization with coils
- May be treated with or without assist devices
Exclusion
Exclusion Criteria:
- Unstable neurological deficit in unruptured cases (condition worsening within last 90days)
- Pre-planned staged procedure of target aneurysm
- mRS score 3 or more
- Hunt Hess Score more than 3 for subjects with ruptured aneurysm
- Evidence of active infection (e.g.,fever, temperature >38 degrees C and/or WBC >15,000)
Study Design
Total Participants: 164
Treatment Group(s): 1
Primary Treatment: i-ED COIL
Phase:
Study Start date:
December 13, 2022
Estimated Completion Date:
October 31, 2025
Study Description
Connect with a study center
McLaren Health Care
Grand Blanc, Michigan 48439
United StatesActive - Recruiting
Northwell Health Lenox Hill Hospital
New York, New York 10075
United StatesActive - Recruiting
Cleveland Clinic
Cleveland, Ohio 44195
United StatesActive - Recruiting
SSM Health St. Anthony's Hospital
Oklahoma City, Oklahoma 73102
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.